| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8519191 | Contemporary Clinical Trials Communications | 2018 | 14 Pages |
Abstract
The decentralized setting was operationally feasible and well accepted by patients. Faster recruitment and improved access to patients was observed in the decentralized arm. This study supports broader adoption of the decentralized model in clinical trials, though further investigations in larger interventional trials are needed to confirm the benefits from this patient-centric approach.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
Carsten Sommer, Diego Zuccolin, Valdo Arnera, Nicole Schmitz, Pernilla Adolfsson, Nicoletta Colombo, Raphaelle Gilg, Bryan McDowell,